medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2016, Number 3

<< Back

Dermatología Cosmética, Médica y Quirúrgica 2016; 14 (3)

Quiz/Chromoblastomycosis

Treviño FF, Salas-Alanís JC, Trejo CAI, Moreno TMG, Bonifaz A

Language: Spanish
References: 32
Page: 252-253
PDF size: 118.14 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Bada M, Arenas R, Vergara L. Cromoblastomicosis en Veracruz. Un caso curado con extirpación quirúrgica. Med Int Mex, 2012; 28(2): 192-5.

  2. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 5a ed. México: McGraw-Hill; 2013.

  3. Krzys´ciak PM, Pindycka-Piaszczyn´ska M, Piaszczyn´ski M. Chromoblastomycosis, Derm Alergol, 2014; 31(5): 310-21.

  4. Queiroz-Telles F, Esterre P, Pérez-Blanco M et al. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol, 2009; 47(1): 3-15.

  5. Correia RT, Valente NY, Criado PR, Martins JE. Chromoblastomycosis: study of 27 cases and review of medical literature, An Bras Dermatol, 2010; 85(4): 448-54.

  6. Minotto R, Bernardi CD, Mallman LF et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol, 2001; 44(4): 585-92.

  7. Castro L, De Andrade TS. Chromoblastomycosis: still a therapeutic challenge. Expert Rev Dermatol, 2010; 5(4): 433-43.

  8. De Hernández F. Cromoblastomicosis. México: Departamento de Microbiología y Parasitología-unam. Disponible en: http://www.facmed. unam.mx/deptos/microbiologia/micologia/cromoblastomicosis.html.

  9. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses, 2001; 44(1-2): 1-7.

  10. Queiroz-Telles F, Santos DW. Challenges in the therapy of chromoblastomycosis. Mycopathologia, 2013; 175(5-6): 477-88.

  11. Bonifaz A, Saul A, Paredes-Solís V et al. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatolog Treat, 2005; 16(1): 47-51.

  12. Esterre P, Inzan CK, Rtasioharana M et al. A multicenter trial of terbinafine in patients with chromoblastomycosis: effects on clinical and biological criteria. J Dermatolog Treat, 1998; 9(1): S29-34.

  13. Queiroz-Telles F, Purim KS, Fillus JN et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol, 1992; 31(11): 805-12.

  14. Queiroz-Telles F, Santos DW. Chromoblastomycosis in the clinical practice. Curr Fungal Infect Rep, 2012; 6(4): 312-9.

  15. Restrepo A, González A, Gómez I et al. Treatment of chromoblastomycosis with itraconazole, Ann N Y Acad Sci, 1988; 544: 504-16.

  16. Antonello VS, Da Silva MC, Cambruzzi E et al. Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association. Rev Inst Med Trop Sao Paulo, 2010; 52(6): 329-31.

  17. Bada M, Arenas R, Vergara L. Cromoblastomicosis en Veracruz. Un caso curado con extirpación quirúrgica. Med Int Mex, 2012; 28(2): 192-5.

  18. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 5a ed. México: McGraw-Hill; 2013.

  19. Krzys´ciak PM, Pindycka-Piaszczyn´ska M, Piaszczyn´ski M. Chromoblastomycosis, Derm Alergol, 2014; 31(5): 310-21.

  20. Queiroz-Telles F, Esterre P, Pérez-Blanco M et al. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol, 2009; 47(1): 3-15.

  21. Correia RT, Valente NY, Criado PR, Martins JE. Chromoblastomycosis: study of 27 cases and review of medical literature, An Bras Dermatol, 2010; 85(4): 448-54.

  22. Minotto R, Bernardi CD, Mallman LF et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol, 2001; 44(4): 585-92.

  23. Castro L, De Andrade TS. Chromoblastomycosis: still a therapeutic challenge. Expert Rev Dermatol, 2010; 5(4): 433-43.

  24. De Hernández F. Cromoblastomicosis. México: Departamento de Microbiología y Parasitología-unam. Disponible en: http://www.facmed. unam.mx/deptos/microbiologia/micologia/cromoblastomicosis.html.

  25. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses, 2001; 44(1-2): 1-7.

  26. Queiroz-Telles F, Santos DW. Challenges in the therapy of chromoblastomycosis. Mycopathologia, 2013; 175(5-6): 477-88.

  27. Bonifaz A, Saul A, Paredes-Solís V et al. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatolog Treat, 2005; 16(1): 47-51.

  28. Esterre P, Inzan CK, Rtasioharana M et al. A multicenter trial of terbinafine in patients with chromoblastomycosis: effects on clinical and biological criteria. J Dermatolog Treat, 1998; 9(1): S29-34.

  29. Queiroz-Telles F, Purim KS, Fillus JN et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol, 1992; 31(11): 805-12.

  30. Queiroz-Telles F, Santos DW. Chromoblastomycosis in the clinical practice. Curr Fungal Infect Rep, 2012; 6(4): 312-9.

  31. Restrepo A, González A, Gómez I et al. Treatment of chromoblastomycosis with itraconazole, Ann N Y Acad Sci, 1988; 544: 504-16.

  32. Antonello VS, Da Silva MC, Cambruzzi E et al. Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association. Rev Inst Med Trop Sao Paulo, 2010; 52(6): 329-31.




2020     |     www.medigraphic.com